Compound ID | 3574
DCB001
Synonym(s): DCB-001 | DCB 001
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus including multidrug-resistant strains and methicillin-resistant strains |
| Propensity to select resistant mutants: | No |
| Description: | Synthetic compound; trichloroacetimidamide (TriCA2); N-(azol-2-yl)imidamide scaffold; shows efficacy in treating methicillin-resistant Staphylococcus aureus bacteraemia infection model with comparable outcomes to vancomycin and ampicillin |
| Institute where first reported: | DimiCare Biotech (Nice, France) |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.dimicare-biotech.com/pipeline/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.